Actualités et Activités de SurModics
Présence
SurModics fait partie des...
SurModics est une société cotée sous le symbole boursier SRDX (US).
Acquisition, funding and merger involving SurModics.
- GTCR has announced the acquisition of SurModics (publié le 3 juin 2024).
Dirigeants
Voir l'organigramme avec ses 31 principaux dirigeants
Biographies les plus recherchées chez SurModics
- Gary Maharaj, President and Chief Executive Officer, Director
- Jose Bedoya, Director
- Lisa Heine, Director
Changements de dirigeants chez SurModics
- Tom Worthington, National Sales Director, a quitté l'entreprise (publié le 5 novembre 2024).
Créer une alerte
pour suivre les mouvements de dirigeants chez SurModics.
Chimie
SurModics a 1 013 concurrents dont BASF (Allemagne), Air Liquide (France) et AkzoNobel (Pays—Bas).
Actualités en fusion/acquisition en Chimie.
- Granules India a acquis Senn Chemicals (publié le 14 avril 2025).
- Pritzker Private Capital has announced the acquisition of Americhem (publié le 24 février 2025).
- Piedmont Lithium and Sayona Mining have announced they will merge (publié le 19 novembre 2024)..
Contacts en Chimie
Actualités
Derniers communiqués de presse par SurModics
- Surmodics Announces Commercial Release of Pounce™ XL Thrombectomy System, Enabling Rapid Non-Surgical Clot Removal in Iliac and Femoral Arteries | Surmodics, Inc.
- Surmodics Issues Statement on U.S. Federal Trade Commission Challenge to Proposed Acquisition of Surmodics by Funds Affiliated with GTCR | Surmodics, Inc.
- Surmodics Reports First Quarter of Fiscal Year 2025 Financial Results | Surmodics, Inc.
- Surmodics Announces Successful Early Clinical Use of Pounce™ XL Thrombectomy System, Suitable for Non-Surgical Removal of Thrombi and Emboli from Iliac and Femoral Arteries | Surmodics, Inc.
- News Releases | Surmodics, Inc.
- Surmodics Reports Fourth Quarter and Fiscal Year 2024 Financial Results | Surmodics, Inc.
- Surmodics Announces Early Results from PROWL Registry Study of Real-World Limb Ischemia Patients Treated with Pounce™ Thrombectomy System | Surmodics, Inc.
- Surmodics Receives FDA 510(k) Clearance for Pounce™ XL Thrombectomy System, Expanding the Pounce Thrombectomy Platform to Larger Peripheral Arteries up to 10 mm in Diameter | Surmodics, Inc.
- Surmodics Reports Third Quarter of Fiscal Year 2024 Financial Results | Surmodics, Inc.
- Surmodics Awarded Thrombectomy Products Agreement with Premier, Inc. | Surmodics, Inc.
- Voir plus de communiqués de presse Close
Réseaux sociaux à propos de SurModics
- SurModics sur Wikipédia, Google News & Yahoo Finance en 1-click
- SurModics sur LinkedIn, Twitter & YouTube en 1-click
